Nasdaq Down More Than 100 Points; Gold Falls 1%
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday.
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday’s Mid-Day Session
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday.
Wedbush Downgrades Imago BioSciences to Neutral, Raises Price Target to $36
Wedbush analyst Robert Driscoll downgrades Imago BioSciences (NASDAQ:IMGO) from Outperform to Neutral and raises the price target from $25 to $36.
HC Wainwright & Co. Maintains Buy Rating for Imago BioSciences: Here’s What You Need To Know
HC Wainwright & Co. has decided to maintain its Buy rating of Imago BioSciences (NASDAQ:IMGO) and lower its price target from $36.00 to $35.00.
Shares of Imago BioSciences are trading down 2.8% over the last 24 hours, at $18.91 per share.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
70 Biggest Movers From Friday
Gainers
GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners.
HC Wainwright & Co. Initiates Coverage On Imago BioSciences with Buy Rating, Announces Price Target of $37
HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Imago BioSciences (NASDAQ:IMGO) with a Buy rating and announces Price Target of $37.